MedPath

Daily Weight Study

Recruiting
Conditions
N17.92
N17.93
Registration Number
DRKS00025586
Lead Sponsor
Charité Universitätsmedizin BerlinKlinik für Nephrologie und internistische Intensivmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

*AKI KDIGO 2 or 3

*No marked haemodynamic instability (noradrenaline up to a maximum of 0.3microg/min, no adrenaline, assessment of the attending physician)

Exclusion Criteria

*Failure to obtain patient consent or revocation of same.

*Ecmo therapy

*Noradrenaline level lower 0,05 microgram/minute

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Daily weighing will give patients a cumulatively lower fluid balance over 7 days after inclusion in the study.
Secondary Outcome Measures
NameTimeMethod
Daily weighing leads to faster recovery from AKI.<br><br>Daily weighing leads to fewer dialysis treatments in the first 4 weeks.<br><br>Daily weighing leads to shorter ITS stay.<br>
© Copyright 2025. All Rights Reserved by MedPath